Arix Bioscience (ARIX) 2022年年度报告「LSE」.pdf

1、Investing in lifechanging scienceAnnual report and accounts 2022Strategic Report1 Highlights2 At a Glance4 Investment Proposition5 Chairmans Statement8 Chief Executive Officers Review11 Market Insight12 Our Investment Strategy13 Business Model14 Our Strategic Objectives15 Key Performance Indicators1

2、6 Portfolio Review18 Broad and Rich Clinical Pipeline19 Core Portfolio23 Public Opportunities Portfolio24 Financial Review27 Risk Management32 Our Stakeholders34 SustainabilityCorporate Governance36 Corporate Governance Report42 Board of Directors44 Report of the Nomination Committee48 Report of the

3、 Audit and Risk Committee52 Directors Remuneration Report69 Directors ReportFinancial Statements73 Independent Auditors Report80 Financial StatementsOther information108 Shareholder Information109 GlossaryArix Bioscience plc is a global venture capital company focused on investing in breakthrough bi

4、otechnology companies to deliver superior risk-adjusted returns to shareholders.ContentsOur PurposeOur GoalOur Values and ExpectationsTo generate superior returns for our investors and to make a tangible difference to patients lives,by investing in a focused portfolio of innovative biotechnology com

5、panies addressing areas of high unmet need in healthcareDelivery of double digit NAV growth through a diversified portfolio of biotechnology investmentsOur values and expectations are at the heart of everything we do and form an important part of our culture.Integrity Respect Transparency Collaborat

6、ion Discipline Accountability1ANNUAL REPORT 2022 ARIX BIOSCIENCE PLCStrategic reportCorporate governanceFinancial statementsOther informationJob No:49002Proof Event:9Black Line Level:5Park Communications Ltd Alpine Way London E6 6LACustomer:Arix BioscienceProject Title:Annual ReportT:0207 055 6500 F